vs
Side-by-side financial comparison of CoastalSouth Bancshares, Inc. (COSO) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
CoastalSouth Bancshares, Inc. is the larger business by last-quarter revenue ($21.3M vs $18.9M, roughly 1.1× Electromed, Inc.). CoastalSouth Bancshares, Inc. runs the higher net margin — 31.7% vs 14.6%, a 17.1% gap on every dollar of revenue. Electromed, Inc. produced more free cash flow last quarter ($2.4M vs $-5.9M).
CoastalSouth Bancshares, Inc. is a U.S.-based regional bank holding company. It provides a full range of personal and commercial banking services including deposit accounts, consumer loans, mortgages, commercial financing and wealth management solutions for retail customers and small-to-medium enterprises across the U.S. Gulf Coast region.
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
COSO vs ELMD — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $18.9M |
| Net Profit | $6.7M | $2.8M |
| Gross Margin | — | 78.4% |
| Operating Margin | 41.2% | 19.2% |
| Net Margin | 31.7% | 14.6% |
| Revenue YoY | — | 16.3% |
| Net Profit YoY | — | 40.3% |
| EPS (diluted) | $0.54 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.9M | ||
| Q3 25 | $21.3M | $16.9M | ||
| Q2 25 | $19.9M | $17.4M | ||
| Q1 25 | — | $15.7M | ||
| Q4 24 | — | $16.3M | ||
| Q3 24 | — | $14.7M | ||
| Q2 24 | — | $14.8M | ||
| Q1 24 | — | $13.9M |
| Q4 25 | — | $2.8M | ||
| Q3 25 | $6.7M | $2.1M | ||
| Q2 25 | $6.0M | $2.2M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $1.5M |
| Q4 25 | — | 78.4% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | — | 76.2% | ||
| Q1 24 | — | 74.8% |
| Q4 25 | — | 19.2% | ||
| Q3 25 | 41.2% | 15.8% | ||
| Q2 25 | 35.4% | 17.5% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 15.6% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 13.3% |
| Q4 25 | — | 14.6% | ||
| Q3 25 | 31.7% | 12.6% | ||
| Q2 25 | 30.0% | 12.7% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 10.8% |
| Q4 25 | — | $0.32 | ||
| Q3 25 | $0.54 | $0.25 | ||
| Q2 25 | $0.57 | $0.26 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.16 | ||
| Q2 24 | — | $0.20 | ||
| Q1 24 | — | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $250.4M | $45.4M |
| Total Assets | $2.3B | $54.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $13.8M | ||
| Q3 25 | — | $14.1M | ||
| Q2 25 | — | $15.3M | ||
| Q1 25 | — | $15.2M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | — | $13.9M | ||
| Q2 24 | — | $16.1M | ||
| Q1 24 | — | $11.7M |
| Q4 25 | — | $45.4M | ||
| Q3 25 | $250.4M | $44.7M | ||
| Q2 25 | $209.4M | $43.2M | ||
| Q1 25 | — | $43.9M | ||
| Q4 24 | — | $43.6M | ||
| Q3 24 | — | $41.5M | ||
| Q2 24 | — | $44.5M | ||
| Q1 24 | — | $42.5M |
| Q4 25 | — | $54.9M | ||
| Q3 25 | $2.3B | $53.6M | ||
| Q2 25 | $2.2B | $53.8M | ||
| Q1 25 | — | $52.5M | ||
| Q4 24 | — | $52.3M | ||
| Q3 24 | — | $48.9M | ||
| Q2 24 | — | $52.2M | ||
| Q1 24 | — | $48.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $3.0M |
| Free Cash FlowOCF − Capex | $-5.9M | $2.4M |
| FCF MarginFCF / Revenue | -27.7% | 12.7% |
| Capex IntensityCapex / Revenue | 1.9% | 3.4% |
| Cash ConversionOCF / Net Profit | -0.82× | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.0M | ||
| Q3 25 | $-5.5M | $169.0K | ||
| Q2 25 | $-16.8M | $3.9M | ||
| Q1 25 | — | $2.1M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $1.4M |
| Q4 25 | — | $2.4M | ||
| Q3 25 | $-5.9M | $-83.0K | ||
| Q2 25 | $-17.9M | $3.7M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $1.3M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | -27.7% | -0.5% | ||
| Q2 25 | -90.3% | 21.4% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 30.1% | ||
| Q1 24 | — | 9.1% |
| Q4 25 | — | 3.4% | ||
| Q3 25 | 1.9% | 1.5% | ||
| Q2 25 | 5.5% | 0.8% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 1.10× | ||
| Q3 25 | -0.82× | 0.08× | ||
| Q2 25 | -2.82× | 1.75× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | — | 1.60× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.46× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COSO
Segment breakdown not available.
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
